# The INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial (INSTANT)

> **NCT01454440** · PHASE4 · TERMINATED · sponsor: **University of Turin, Italy** · enrollment: 91 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Eptifibatide

## Key facts

- **NCT ID:** NCT01454440
- **Lead sponsor:** University of Turin, Italy
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-10
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 91 (ACTUAL)
- **Why stopped:** The study was stopped prematurely due to slow enrolment without code breaking.
- **Last updated:** 2011-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01454440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01454440, "The INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial (INSTANT)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01454440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*